ArticleOncotarget2024

Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.

Josette Northcott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.